Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yi-Qiong Guo"'
Autor:
Lu-Lu Gao, Yu-Xiang Li, Jia-Min Ma, Yi-Qiong Guo, Lin Li, Qing-Han Gao, Yan-Na Fan, Meng-Wei Zhang, Xiu-Juan Tao, Jian-Qiang Yu, Jian-Jun Yang
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Non-alcohol fatty liver disease (NAFLD) is the most common chronic liver disease in the world, with a high incidence and no effective treatment. At present, the targeted therapy of intestinal microbes for NAFLD is highly valued. L
Externí odkaz:
https://doaj.org/article/019eef49540a4b199615f91b4e5fc50b
Autor:
Lu-Lu Gao, Yu-Xiang Li, Jia-Min Ma, Yi-Qiong Guo, Lin Li, Qing-Han Gao, Yan-Na Fan, Meng-Wei Zhang, Xiu-Juan Tao, Jian-Qiang Yu, Jian-Jun Yang
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/01c8103b00854172bda81e96ffc1ebd1
Publikováno v:
Chinese Journal of Integrative Medicine. 28:975-982
To explore the protective effect and underlying mechanism of Lycium barbarum polysaccharides (LBP) in a non-alcoholic fatty liver disease (NAFLD) cell model.Normal human hepatocyte LO2 cells were treated with 1 mmol/L free fatty acids (FFA) mixture f
Autor:
Jia-Min Ma, Qing-Han Gao, Yi-Qiong Guo, Meng-Wei Zhang, Jian-Qiang Yu, Lu-Lu Gao, Lin Li, Xiu-Juan Tao, Yanna Fan, Yu-Xiang Li, Jian-Jun Yang
Publikováno v:
Trials
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Background Non-alcohol fatty liver disease (NAFLD) is the most common chronic liver disease in the world, with a high incidence and no effective treatment. At present, the targeted therapy of intestinal microbes for NAFLD is highly valued. Lycium bar